Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;134(2):187-92.
doi: 10.1007/s00432-007-0268-z. Epub 2007 Jul 5.

Palliative gastrectomy and chemotherapy for stage IV gastric cancer

Sheng-Zhang Lin  1 , Hong-Fei Tong, Tao You, Yao-Jun Yu, Wei-Jun Wu, Cong Chen, Wei Zhang, Bing Ye, Chun-Ming Li, Zhi-Qiang Zhen, Jia-Rong Xu, Jun-Liang Zhou
Affiliations

Palliative gastrectomy and chemotherapy for stage IV gastric cancer

Sheng-Zhang Lin et al. J Cancer Res Clin Oncol. 2008 Feb.

Abstract

Purpose: To investigate the value of palliative gastrectomy and chemotherapy in a large series of patients with stage IV gastric cancer.

Methods: A total of 389 patients were identified in survival analysis. Among which, 183 cases received palliative gastrectomy (PG) and 206 cases received unresectable operation, 184 cases received palliative chemotherapy (PC) and 205 cases did not receive chemotherapy. The survival advantages of patients, based on treatments modality, were also analyzed in patients with liver metastasis, peritoneal dissemination and lymph node metastasis.

Results: The 1-year, 3-year, 5-year survival rate of those patients who were treated with PG + PC were 85.7% (96/112), 32.1% (36/112), and 8.9% (10/112), which were far better than those who were not. For those patients with liver metastasis, peritoneal dissemination, and/or N3 lymph node metastasis, survival advantages were also present if treated with this multimodality approach.

Conclusion: The survival time and palliative duration were significantly longer in patients after PG than after non-resection operations. Postoperative chemotherapy prolonged the survival time of patients after palliative surgery. PG combined with adjuvant chemotherapy may improve survival in patients with stage IV gastric cancer, even with liver metastasis, peritoneal dissemination, and lymph node metastasis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Survival time of patients with stage IV gastric cancer based on treatments modality. PG palliative gastrectomy, UO unresectable operation, PC palliative chemotherapy, NC no chemotherapy
See this image and copyright information in PMC

References

    1. AJCC (2003) Cancer staging manual, 6th edn, Springer, New York
    1. Doglietto GB, Pacelli F, Caprino P, Alfieri S, Carriero C, Malerba M, Crucitti (1999) Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 65:352–355 - PubMed
    1. Kakeji Y, Maehara Y, Tomoda M, Kabashima A, Ohmori M, Oda S, Ohno S, Sugimachi K (1998) Long-term survival of patients with stage IV gastric carcinoma. Cancer 82:2307–2311 - PubMed
    1. Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T, Kito T (1997) Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer. J Am Coll Surg 185:65–69 - PubMed
    1. Lawrence W Jr, McNeer G (1958) The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 11:28–32 - PubMed

MeSH terms